D-0085-2018 Class II Terminated

Recalled by Leading Pharma, LLC — Fairfield, NJ

FDA drug recall D-0085-2018 was initiated by Leading Pharma, LLC on Sep 28, 2017 and is designated Class II. Reason for recall: Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam The recall status is terminated (terminated Sep 21, 2020). Affected quantity: 2952 500-count bottles.

Recall details

Product Type
Drugs
Report Date
Nov 29, 2017
Initiation Date
Sep 28, 2017
Termination Date
Sep 21, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2952 500-count bottles

Product description

Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05

Reason for recall

Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam

Distribution pattern

Nationwide in the USA

Code information

Lot #E00717

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0085-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0085-2018. Report a data issue: hello@regdatalab.com.